Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulating, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulating (FBTU.L) has returned -5.44% so far this year and 18.72% over the past 12 months.
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulating
- 1D
- 2.87%
- 1M
- -4.92%
- YTD
- -5.44%
- 6M
- 12.00%
- 1Y
- 18.72%
- 3Y*
- 8.81%
- 5Y*
- 3.92%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since May 29, 2020, FBTU.L's average daily return is +0.02%, while the average monthly return is +0.40%. At this rate, your investment would double in approximately 14.5 years.
Historically, 57% of months were positive and 43% were negative. The best month was Dec 2023 with a return of +12.1%, while the worst month was Oct 2023 at -10.3%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 3 months.
On a daily basis, FBTU.L closed higher 50% of trading days. The best single day was Nov 4, 2020 with a return of +7.3%, while the worst single day was Apr 9, 2025 at -6.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 1.56% | -2.07% | -4.92% | -5.44% | |||||||||
| 2025 | 10.31% | -5.20% | -4.07% | -3.81% | 0.85% | -0.28% | 4.05% | 2.30% | 2.93% | 8.43% | 11.53% | -2.05% | 25.95% |
| 2024 | -5.74% | 1.25% | 1.19% | -5.82% | 2.84% | 3.52% | 8.76% | 1.07% | 1.56% | -1.33% | 2.60% | -4.29% | 4.74% |
| 2023 | 6.29% | -5.57% | 0.23% | -0.72% | -0.69% | 0.44% | 1.53% | 0.27% | -5.45% | -10.27% | 7.69% | 12.13% | 3.91% |
| 2022 | -10.22% | 0.15% | 2.51% | -7.33% | -2.94% | 0.53% | 2.57% | -1.73% | -1.29% | 6.56% | 4.96% | 1.40% | -5.96% |
| 2021 | 5.11% | -6.40% | -3.98% | 3.33% | -0.96% | 5.42% | -1.96% | 2.61% | -3.54% | -1.08% | -5.95% | 4.57% | -3.77% |
Benchmark Metrics
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulating has an annualized alpha of -0.07%, beta of 0.40, and R² of 0.10 versus S&P 500 Index. Calculated based on daily prices since June 01, 2020.
- This ETF participated in 92.55% of S&P 500 Index downside but only 57.52% of its upside — more exposed to losses than it benefited from rallies.
- Beta of 0.40 may look defensive, but with R² of 0.10 this ETF is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this ETF's risk.
- R² of 0.10 means this ETF moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -0.07%
- Beta
- 0.40
- R²
- 0.10
- Upside Capture
- 57.52%
- Downside Capture
- 92.55%
Expense Ratio
FBTU.L has an expense ratio of 0.60%, placing it in the medium range.
Return for Risk
Risk / Return Rank
FBTU.L ranks 42 for risk / return — on par with similar ETFs. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulating (FBTU.L) and compare them to a chosen benchmark (S&P 500 Index).
| FBTU.L | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.81 | 0.90 | -0.08 |
Sortino ratioReturn per unit of downside risk | 1.26 | 1.39 | -0.13 |
Omega ratioGain probability vs. loss probability | 1.16 | 1.21 | -0.05 |
Calmar ratioReturn relative to maximum drawdown | 1.26 | 1.40 | -0.14 |
Martin ratioReturn relative to average drawdown | 3.61 | 6.61 | -3.00 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore FBTU.L risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulating. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulating was 33.73%, occurring on Jun 14, 2022. Recovery took 833 trading sessions.
The current First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulating drawdown is 11.52%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -33.73% | Feb 10, 2021 | 337 | Jun 14, 2022 | 833 | Oct 1, 2025 | 1170 |
| -16.4% | Jul 21, 2020 | 22 | Sep 4, 2020 | 99 | Jan 26, 2021 | 121 |
| -14.3% | Jan 23, 2026 | 40 | Mar 19, 2026 | — | — | — |
| -4.58% | Jan 8, 2026 | 8 | Jan 19, 2026 | 3 | Jan 22, 2026 | 11 |
| -4.55% | Jun 11, 2020 | 2 | Jun 12, 2020 | 5 | Jun 19, 2020 | 7 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...